BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4365816)

  • 1. Proceedings: Plasma levels of amino acids and glucagon in patients with pancreatic glucagonomas.
    Mallinson CN; Cox B; Bloom SR
    Gut; 1974 Apr; 15(4):340. PubMed ID: 4365816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 3. The glucagonoma syndrome.
    Weir GC; Novelline RA
    Am Fam Physician; 1977 Jul; 16(1):83-4. PubMed ID: 195450
    [No Abstract]   [Full Text] [Related]  

  • 4. A glucagonoma syndrome.
    Mallinson CN; Bloom SR; Warin AP; Salmon PR; Cox B
    Lancet; 1974 Jul; 2(7871):1-5. PubMed ID: 4134714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iatrogenic glucagonoma syndrome?].
    Benhamou PY; Reymond JL; Boizel R; Béani JC; Amblard P
    Ann Dermatol Venereol; 1988; 115(6-7):717-9. PubMed ID: 2849361
    [No Abstract]   [Full Text] [Related]  

  • 6. [The glucagonomas (author's transl)].
    Luyckx AS; Lefebvre PJ
    Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pancreatic function tests].
    Abe M; Ikeda Y; Yaginuma M; Shimizu N
    Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrolytic migratory erythema with glucagon-secreting tumour of the pancreas.
    Warin AP
    Proc R Soc Med; 1974 Oct; 67(10):1008-10. PubMed ID: 4372637
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
    Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
    Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucagonoma syndrome.
    Shupack JL; Berczeller PH; Stevens DM
    J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucagonoma syndrome and its management.
    Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1977; 9(5):419-24. PubMed ID: 201809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some observations on blood amino acid concentrations during L-leucine loading tests on a patient with an insulin producing tumor.
    Hayashi T; Nagai S; Misugi Y; Yamaguchi H
    Bull Osaka Med Sch; 1975 Jul; 21(1):9-18. PubMed ID: 178394
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: The association of a specific skin lesion with islet-cell tumours of the pancreas.
    Mallinson CN; Salmon PR; Borrowman J; Bloom S
    Gut; 1973 Oct; 14(10):827. PubMed ID: 4357152
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical aspects of glucagon-producing islet cell tumors.
    Prinz RA; Dorsch TR; Lawrence AM
    Am J Gastroenterol; 1981 Aug; 76(2):125-31. PubMed ID: 6272569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of glucagonoma].
    Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 17. Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma.
    Leichter SB; Pagliara AS; Grieder MH; Pohl S; Rosai J; Kipnis DM
    Am J Med; 1975 Feb; 58(2):285-93. PubMed ID: 46704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour.
    Oberg K; Wide L; Boström H
    Acta Med Scand; 1981; 210(3):231-3. PubMed ID: 6270988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.